Kodiak Sciences Inc (KOD)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Net income
- -229,967,000
- Operating income
- -234,388,000
- Earnings per share
- -4.32
- R&D expense
- 182,373,000
Growth and profitability
- Return on equity
- -146.12
- Return on assets
- -65.42
Balance sheet
- Total assets
- 351,533,000
- Total liabilities
- 194,150,000
- Shareholders' equity
- 157,383,000
- Cash and equivalents
- 209,862,000
- Current ratio
- 4.72
Cash flow and ratios
- Operating cash flow
- -136,008,000
- Free cash flow
- -136,514,000
Shareholder returns
- Shares outstanding
- 65,395,553
- Book value per share
- 2.41
Company information
- Headquarters
- Palo Alto, CA
- Exchange
- NASDAQ
- Fiscal year end
- 12-31
- Industry (SEC)
- Biological Products, (no Diagnostic Substances)
Fiscal year end: · Source: SEC EDGAR
Kodiak Sciences Inc trades on NASDAQ under the ticker symbol KOD. This page brings together its price chart, company profile, key financial figures and technical indicators.